India's Richest People 2026 edition · 1 director · Source: Hurun India
- #678 Sunil Siddharth Lalbhai & Family ₹4,700 Cr
Revenue · FY 2025
₹136.8 Cr
▲ 3% YoY
Net profit · FY 2025
₹2.58 Cr
Net margin 1.9%
EBITDA · FY 2025
₹14.88 Cr
EBITDA margin 10.9%
Authorised capital
₹60 Cr
Registered with MCA
Paid-up capital
₹29.02 Cr
Issued & subscribed
Open charges
₹45 Cr
Satisfied ₹58.75 Cr
Company age
29 yrs
Est. 1997
Employees · EPFO
186
Provident fund records
About Atul Bioscience Limited
Data last updated:
Atul Bioscience Limited is a public limited company based in Atul, Gujarat, India, a subsidiary of Atul Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 21 May 1997 and has been in existence for over 29 years.
Its director Sunil Siddharth Lalbhai and Family is #678 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ1997PLC032369. Its GSTIN is 24AACCA0331P1ZX (Gujarat). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹60 Cr and a paid-up capital of ₹29.02 Cr. It was formerly known as Atul Pharmaceuticals Limited. It is led by directors including Prabhakar Chebiyyam (Managing Director) and Rangaswamy Rathakrishnan Iyer.
Its last annual general meeting (AGM) was held on 10 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 12 East Site, Atul, Gujarat, India – 396020.
As per the financials filed for FY 2025, the company reported a revenue of ₹136.8 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹2.58 Cr (net margin 1.9%) and EBITDA of ₹14.88 Cr (EBITDA margin 10.9%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 5% over five years.
The company has about 186 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Atul. As per MCA filings, the company has open charges of ₹45 Cr and satisfied charges of ₹58.75 Cr on record. Court records list 211 cases involving the company, including 211 filed against it; 6 cases are pending. The company has 8 deals on record (6 funding rounds, 2 secondary share transfers), with disclosed funding of ₹54.95 Cr; the latest was in February 2019. Its 7 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Azico Biophore India Private Limited with revenue of ₹140.48 Cr. The company has 9 MSME Form 1 returns on record between 2020 and 2024, listing 248 overdue payments to 92 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website atulbio.co.in.
Company details
CIN U24230GJ1997PLC032369
Registration Number 032369
Incorporation Date 21 May 1997
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 10 July 2025
Date of Balance Sheet 31 March 2025
Parent Company Atul Limited
Compliance Status Active Compliant
CIN history
Atul Bioscience has one previous CIN (Corporate Identification Number): U24230GJ1997PTC032369. The current CIN is U24230GJ1997PLC032369, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230GJ1997PLC032369 | Current |
| U24230GJ1997PTC032369 | Previous |
Key People
Prabhakar Chebiyyam Managing Director Rangaswamy Rathakrishnan Iyer Director Latika Prakash Pradhan Director Recognitions & Rankings of Atul Bioscience
Contact details
Atul Bioscience Limited's registered office is in Atul, Gujarat. Its website is atulbio.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressE – 12 East Site, Atul, Gujarat, India – 396020
- IndustryPharma, API Manufacturers
To see the full contact details of Atul Bioscience Limited, buy the company report.
Comprehensive company report
Atul Bioscience Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Atul Bioscience operates one associated brand: Atul. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Fine chemicals are manufactured by Atul in Ahmedabad, India. | atul.co.in |
Business activity
The main business activity of Atul Bioscience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Atul Bioscience Limited, buy the company report.
Financials of Atul Bioscience Limited
FY 2025 filings availableAtul Bioscience Limited reported revenue of ₹136.8 Cr (up 3% YoY) for FY 2025.
Revenue · FY 2025
₹136.8 Cr ▲ 3%
Net profit · FY 2025
₹2.58 Cr margin 1.9%
EBITDA · FY 2025
₹14.88 Cr margin 10.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 3%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 22%
3 years · compounded
▼ 2%
5 years · compounded
▲ 3%
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 3% growth in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.88 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.58 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.9% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Atul Bioscience Limited, buy the company report.
Board of directors of Atul Bioscience Limited
Atul Bioscience has 9 current directors and 20 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rangaswamy Rathakrishnan Iyer | Director | 19 Jan 2011 | 15 Years 9 Months | Current |
| Latika Prakash Pradhan Also directs: Aragen Biologics Private Limited | Director | 22 Oct 2021 | 5 Years 0 Months | Current |
| Pramod Hari Lele Also directs: Tatvag Research Foundation, Healthbridge Advisors Private Limited, Valsad Institute of Medical Sciences Limited and 1 more | Director | 19 Jan 2011 | 15 Years 9 Months | Current |
| Prabhakar Chebiyyam Also directs: Atul Lifescience Limited, Atul Healthcare Limited | Managing Director | 11 Jul 2014 | 12 Years 4 Months | Current |
| Sunil Siddharth Lalbhai Also directs: Britannia Industries Ltd, The Bombay Dyeing and Manufacturing Company Limited, Amal Limited and 4 more | Director | 11 Dec 2008 | 17 Years 11 Months | Current |
| Astha Sunil Lalbhai Also directs: Atul Consumer Products Limited, Aagam Holdings Private Limited | Director | 12 Oct 2018 | 8 Years 0 Months | Current |
Showing 6 of 9 current directors. View all directors
Peer comparison
Atul Bioscience Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Azico Biophore India Private Limited | ₹140.48 Cr (FY 2024) | 25.0% | Hyderabad, Telangana, India | |||
| Silicon Life Sciences Private Limited | ₹139.2 Cr (FY 2020) | 31.0% | Hyderabad, Telangana, India | |||
| Satyadeeptha Pharmaceuticals Limited | ₹138.74 Cr (FY 2025) | -31.0% | Humnabad, Karnataka, India | |||
| Atul Bioscience Limitedthis company | ₹136.8 Cr (FY 2025) | ₹2.58 Cr | 1.9% | 3.0% | 186 | Atul, Gujarat, India |
| Lasa Laboratory Private Limited | ₹136.67 Cr (FY 2016) | 92.0% | Badlapur, Maharashtra, India | |||
| Corvine Chemicals and Pharmaceuticals Private Limited | ₹136.26 Cr (FY 2025) | 10.0% | Bidar, Karnataka, India | |||
| Kinvan Private Limited | ₹135.98 Cr (FY 2025) | 11959.0% | Solan, Himachal Pradesh, India | |||
| R.N. Laboratories Private Limited | ₹135.13 Cr (FY 2025) | 19.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Atul Bioscience Limited, buy the company report.
Auditor
Atul Bioscience Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells LLP | FY 2024 | 117366W/W-100018 |
Shareholding
The shareholding of Atul Bioscience Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Atul Bioscience Limited, buy the company report.
Charges & borrowings
Open charges
₹45 Cr
Satisfied charges
₹58.75 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Jul 2024 | 100950233 | Others | ₹40 Cr | Open | |
| 07 Jun 2011 | 10291318 | Axis Bank Limited | ₹5 Cr | Open | |
| 08 Mar 2019 | 100250831 | Others | ₹40 Cr | Satisfied | |
| 25 Jul 2012 | 10372967 | Axis Bank Ltd | ₹7.5 Cr | Satisfied | |
| 07 Jun 2011 | 10291233 | Axis Bank Limited | ₹11.25 Cr | Satisfied |
To see the full charge records of Atul Bioscience Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Atul Bioscience Limited has 8 deals on record (6 funding rounds, 2 secondary share transfers), with disclosed funding of ₹54.95 Cr; the latest was in February 2019.
Total deals
8
Funding rounds
6
Secondary share transfers
2
Disclosed funding
₹54.95 Cr
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2019 | Funding round | ₹30 Cr | Investors: Atul Limited |
| Jan 2019 | Funding round | ₹10 Cr | Investors: Atul Limited |
| Mar 2016 | Secondary share transfer | Undisclosed | Seller: Atul Limited |
| Oct 2015 | Funding round | ₹4.56 Cr | Investors: Atul Limited |
| Apr 2012 | Funding round | ₹2.5 Cr | Investors: Atul Limited |
To see the full deal history of Atul Bioscience Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Atul Bioscience Limited has 211 court cases on record: 211 filed against it. 6 cases are pending and 205 are disposed.
Total cases
211
Filed against the company
211
Pending
6
Disposed
205
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 207 | 207 | 6 |
| District courts | 4 | 4 | 0 |
Cases on record (5 of 211)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Arbitration matter | Filed against the company by M/S Terrier Security Services (India) Pvt. Ltd. | Disposed |
| High Court, GUJARAT | Special civil application | Filed against the company by an individual | Pending |
| High Court, GUJARAT | Special civil application | Filed against the company by an individual | Pending |
| High Court, GUJARAT | Special civil application | Filed against the company by an individual | Pending |
| High Court, GUJARAT | Special civil application | Filed against the company by an individual | Pending |
To see the full case history of Atul Bioscience Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Atul Bioscience Limited has 9 MSME Form 1 returns on record between 2020 and 2024, listing 248 overdue payments to 92 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 92)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Classic Exports | |||
| an individual supplier | |||
| Safe Care Corporation | |||
| Modern Industrial Equipments Private Limited | |||
| Elixir Engineering Private Limited |
To see the full MSME payment records of Atul Bioscience Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Atul Bioscience Limited has a workforce of 186 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Employee count
186
Active EPFO establishments
2
Employee growth
-3.1%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 186 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Atul Bioscience Limited, buy the company report.
GST
Atul Bioscience has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCA0331P1ZX | Gujarat | Active | 01 Jul 2017 |
| 27AACCA0331P1ZR | Maharashtra | Active | 01 Jan 2019 |
To see the full GST registrations and return filing status of Atul Bioscience Limited, buy the company report.
Recent activity
Atul Bioscience Limited has 25 board changes on record since 1997: 9 appointments and 16 cessations. The latest: Jagdish Viswanath Dore was appointed as Additional Director on 17 Jan 2025.
AGM
Atul Bioscience Limited last Annual general meeting of members was held on 10 Jul 2025 as per latest MCA records.
Filing
Atul Bioscience Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Axis Bank Limited of Rs. 5.00 Cr registered on 07 Jun 2011 with Charge ID 10291318 was modified on 14 Feb 2025.
Appointed
Jagdish Viswanath Dore was appointed as Additional Director.
Charges
A charge with Others of Rs. 40.00 Cr registered on 05 Jul 2024 with Charge ID 100950233 was modified on 19 Sep 2024.
Charges
A charge with Others amounted to Rs. 40.00 Cr with Charge ID 100950233 was registered on 05 Jul 2024.
Ceased
Latika Prakash Pradhan ceased to be Additional Director.
Ceased
Vivek Yeshwant Gadre ceased to be Additional Director.
Ceased
Suresh Kalra ceased to be Cfo(Kmp).
Appointed
Vivek Yeshwant Gadre was appointed as Director.
Ceased
Sharat Rajendra Tripathi ceased to be Additional Director.
Ceased
Rajeev Kumar ceased to be Company Secretary.
28 earlier events are in the company report.
Frequently asked questions
Atul Bioscience is an active public limited company based in Atul, Gujarat, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 21 May 1997 (29+ years old) and is registered under CIN U24230GJ1997PLC032369.
Atul Bioscience has 9 current directors:
- Prabhakar Chebiyyam - Managing Director
- Rangaswamy Rathakrishnan Iyer - Director
- Latika Prakash Pradhan - Director
- Pramod Hari Lele - Director
- Sunil Siddharth Lalbhai - Director
- Astha Sunil Lalbhai - Director
- Jagdish Viswanath Dore - Additional Director
- Gopi Kannan Rengachari Thirukonda - Director
- Vivek Yeshwant Gadre - Director
The latest financial statements of Atul Bioscience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 10 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Atul Bioscience is 24AACCA0331P1ZX, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AACCA0331P1ZR (Maharashtra).
The CIN (Corporate Identification Number) of Atul Bioscience is U24230GJ1997PLC032369. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Atul Bioscience has 211 court cases on record: 211 filed against it. 6 are pending. Most are in the high courts.
Atul Bioscience was incorporated on 21 May 1997, making it 29+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Atul Bioscience has 8 deals on record (6 funding rounds, 2 secondary share transfers), with disclosed funding of ₹54.95 Cr; the latest was in February 2019.
The peers of Atul Bioscience by revenue are Azico Biophore India Private Limited, Silicon Life Sciences Private Limited, Satyadeeptha Pharmaceuticals Limited, Lasa Laboratory Private Limited, Corvine Chemicals and Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jagdish Viswanath Dore was appointed as Additional Director on 17 Jan 2025. Latika Prakash Pradhan ceased to be Additional Director on 15 Jul 2022. Vivek Yeshwant Gadre ceased to be Additional Director on 15 Jul 2022. Atul Bioscience has 25 board changes on record in total.
Atul Bioscience has 9 MSME Form 1 returns on record between 2020 and 2024, listing 248 overdue payments to 92 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Atul Bioscience can be reached through the website atulbio.co.in. Its registered office is in Atul, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages